e-Projection is a fully integrated consulting firm based in Tokyo, Japan. Our experienced team serves our clients, non-Japanese biotechnology and pharmaceutical companies, with a wide spectrum of penetrating insights into the local market. Our expertise in the pharmaceutical industry spans all areas. We are a true one-stop shop consultancy for our clients to make strategic decisions about the Japanese market
Our clients are industry leaders making well-informed decisions about entering markets.
We help them understand the Japanese market, recognize threats and opportunities and provide a clear idea of the value of their innovation in the Japanese market.
DVM, PhD, MBA,
Founder & President
Pricing & Market Access Consultation
We provide a full range of pricing and market access consultations from the planning stage to post-commercialization.Our clients are able to develop fully integrated global pricing strategies, which contribute to maximizing the value of their product and succeeding commercially in the Japanese market.
Pricing & Market Access
P&L Forecast/Project Valuation
Our P&L forecast/project valuation capabilities are based on our broad experience in the local pharmaceutical market and cutting edge valuation techniques, which will provide strategic implications to maximize the corporate value of our clients.
Sales & Marketing
Clinical Development Strategy Consultation
The combination of our extensive experience in clinical trial design and our intense network within the medical community will provide our clients seeking integrated global development strategies with the best solutions to optimize local development plans as well as to maximize the clinical value of the product in the Japanese market.
MD, PhD, MBA,
Chief Medical Officer
e-Projection can carry out a full range of marketing research activities from KOL interviews, web-based quant surveys to secondary data collection and analysis, in order to generate local insights, make our clients understand the unmet medical need in the marketplace, and to best adapt the profile of the local version of their product.
DVM, PhD, MBA,
Founder & President
Not only identifying the key regulatory requirements needed for the approval of the product, but we offer our clients with value maximization plans within the regulatory window of opportunity and present multiple scenarios in order for our clients to understand the regulatory level playing field in Japan.
We serve biotech, pharma, investors and academic institutions who are interested in bringing their products/technologies to the Japanese market and/or seek business partners from the Chinese market. By applying our “number crunching” capabilities in the BD process, we can support our clients with the tools and weapons to best negotiate with their potential Japanese partners.
Japan Opportunity Assessment
US-based biotech company developing phase II product in US/EU, trying to assess whether to expand development activities into Japan now or later. In planning for an IPO in a few months time, the company needed to ensure that investors understood the true global value of their product.
Business Development Support
US biotech company developing phase III product for treatment of a cardiac disease in a hospital setting. Seeking to investigate the Japanese market for their product, find local partners with expertise in the therapeutic area.
Evaluation of Clinical Value Over Competitors
Swiss-based pharmaceutical company seeking business opportunity to develop their product in Japan. Competitive products for the same disease already existed in the Japanese market. Client needed to assess the clinical value of their product and its potential to succeed in Japan, including any advantage over competitors.
Validation of Clinical Development and Pricing Strategy
A German-based biotech in discussion with a Japanese company about the potential licensing of its product. The product targets the treatment of a disease with large unmet medical need currently receiving little treatment.
The product was finishing its Phase III program in Europe with plans to submit the application for approval to the authorities.
Pricing Strategy for Device and Drug Combination
US-based biotech exploring how to obtain premium pricing for their medical device and drug, individually as well as their combination, for a treatment of eye diseases. Client also sought to gain an understanding of the various ways for reimbursement of this combination procedure.
We understand the China market well. This market is growing significantly as the result of changes and improvements in the regulatory environment and better organization of intellectual property law.
A Chinese company seeking new technology looked to be introduced to the growing market of products from Japan
The client needed our services to overcome challenges associated with linguistic and cultural barriers.